C007297 | 1,6-diaminohexane | "ADGRL3 gene modified form results in increased abundance of 1,6-diaminohexane" | 25445006 |
C111118 | 2',3,3',4',5-pentachloro-4-hydroxybiphenyl | "2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of ADGRL3 mRNA" | 19114083 |
C006551 | 2-amino-2-methyl-1-propanol | 2-amino-2-methyl-1-propanol results in decreased expression of ADGRL3 mRNA | 25088246 |
C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with belinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ADGRL3 mRNA" | 27188386 |
C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with entinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ADGRL3 mRNA" | 27188386 |
C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with panobinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ADGRL3 mRNA" | 27188386 |
C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with trichostatin A co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ADGRL3 mRNA" | 27188386 |
C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ADGRL3 mRNA" | 27188386 |
C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with vorinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ADGRL3 mRNA" | 27188386 |
C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with belinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ADGRL3 mRNA" | 27188386 |
C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with entinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ADGRL3 mRNA" | 27188386 |
C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with panobinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ADGRL3 mRNA" | 27188386 |
C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with trichostatin A co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ADGRL3 mRNA" | 27188386 |
C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ADGRL3 mRNA" | 27188386 |
C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with vorinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ADGRL3 mRNA" | 27188386 |
D000535 | Aluminum | [APP protein modified form binds to Aluminum] which results in increased expression of ADGRL3 mRNA | 21298039 |
D000643 | Ammonium Chloride | Ammonium Chloride affects the expression of ADGRL3 mRNA | 16483693 |
D018501 | Antirheumatic Agents | Antirheumatic Agents results in increased expression of ADGRL3 mRNA | 24449571 |
D001151 | Arsenic | Arsenic results in decreased expression of ADGRL3 mRNA | 19654921 |
C547126 | AZM551248 | AZM551248 results in decreased expression of ADGRL3 mRNA | 22323515 |
C487081 | belinostat | belinostat results in decreased expression of ADGRL3 mRNA | 26272509 |
C487081 | belinostat | "[NOG protein co-treated with belinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ADGRL3 mRNA" | 27188386 |
D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in decreased expression of ADGRL3 mRNA | 21569818 |
D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in increased expression of ADGRL3 mRNA | 22610609 |
D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in decreased expression of ADGRL3 mRNA | 22300585 |
C006780 | bisphenol A | bisphenol A affects the expression of ADGRL3 mRNA | 25181051 |
D019256 | Cadmium Chloride | Cadmium Chloride results in increased methylation of ADGRL3 promoter | 22457795 |
D002737 | Chloroprene | Chloroprene results in increased expression of ADGRL3 mRNA | 23125180 |
D003042 | Cocaine | Cocaine affects the expression of ADGRL3 mRNA | 20187946 |
D016572 | Cyclosporine | Cyclosporine results in decreased expression of ADGRL3 mRNA | 20106945 |
D019422 | Dietary Sucrose | Dietary Sucrose results in increased expression of ADGRL3 mRNA | 26033743 |
C118739 | entinostat | entinostat results in decreased expression of ADGRL3 mRNA | 26272509 |
C118739 | entinostat | "[NOG protein co-treated with entinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ADGRL3 mRNA" | 27188386 |
D004997 | Ethinyl Estradiol | Ethinyl Estradiol affects the expression of ADGRL3 mRNA | 26865667 |
D004997 | Ethinyl Estradiol | Ethinyl Estradiol results in increased expression of ADGRL3 mRNA | 15901920 |
D019833 | Genistein | Genistein results in decreased expression of ADGRL3 mRNA | 26865667 |
D005839 | Gentamicins | Gentamicins results in decreased expression of ADGRL3 mRNA | 22061828 |
C561695 | (+)-JQ1 compound | (+)-JQ1 compound results in decreased expression of ADGRL3 mRNA | 26752646 |
D018817 | N-Methyl-3,4-methylenedioxyamphetamine | "N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of ADGRL3 mRNA" | 20188158 |
C008493 | methylselenic acid | methylselenic acid results in increased expression of ADGRL3 mRNA | 18548127 |
D037742 | Nanotubes, Carbon | "Nanotubes, Carbon analog results in decreased expression of ADGRL3 mRNA" | 25554681 |
D037742 | Nanotubes, Carbon | "Nanotubes, Carbon results in decreased expression of ADGRL3 mRNA" | 25554681 |
D009532 | Nickel | Nickel results in decreased expression of ADGRL3 mRNA | 24768652|2558310 |
C496932 | panobinostat | "[NOG protein co-treated with panobinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ADGRL3 mRNA" | 27188386 |
C496932 | panobinostat | panobinostat results in decreased expression of ADGRL3 mRNA | 26272509 |
C006253 | pirinixic acid | pirinixic acid results in decreased expression of ADGRL3 mRNA | 20813756 |
D011192 | Potassium Dichromate | Potassium Dichromate affects the expression of ADGRL3 mRNA | 23608068 |
D011441 | Propylthiouracil | Propylthiouracil affects the expression of ADGRL3 mRNA | 24780913 |
C502851 | quinocetone | quinocetone results in increased expression of ADGRL3 mRNA | 27046791 |
D012822 | Silicon Dioxide | Silicon Dioxide analog results in decreased expression of ADGRL3 mRNA | 25895662 |
D012834 | Silver | Silver results in decreased expression of ADGRL3 mRNA | 27131904 |
D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in decreased expression of ADGRL3 mRNA | 19465110 |
D013849 | Thimerosal | Thimerosal results in increased expression of ADGRL3 mRNA | 27188386 |
C009495 | titanium dioxide | titanium dioxide affects the expression of ADGRL3 mRNA | 23557971 |
D014028 | Tobacco Smoke Pollution | Tobacco Smoke Pollution affects the expression of ADGRL3 mRNA | 20133372 |
C012589 | trichostatin A | "[NOG protein co-treated with trichostatin A co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ADGRL3 mRNA" | 27188386 |
C012589 | trichostatin A | trichostatin A results in decreased expression of ADGRL3 mRNA | 24935251|2627250 |
D014635 | Valproic Acid | "[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ADGRL3 mRNA" | 27188386 |
D014635 | Valproic Acid | Valproic Acid affects the expression of ADGRL3 mRNA | 25979313 |
D014635 | Valproic Acid | Valproic Acid results in decreased expression of ADGRL3 mRNA | 23179753|2627250 |
C111237 | vorinostat | "[NOG protein co-treated with vorinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ADGRL3 mRNA" | 27188386 |
C111237 | vorinostat | vorinostat results in decreased expression of ADGRL3 mRNA | 26272509|2718838 |